SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon ...
The Echo® MS+ system unlocks enhanced high-throughput screening capability by bringing acoustic ejection mass spectrometry (AEMS) approaches to the SCIEX ZenoTOF 7600 system. FRAMINGHAM, Mass.-SCIEX, ...
This article is based on a poster originally authored by Ariane Jonetz-Mentzel et al. In biopharmaceutical laboratories, there is an increasing demand for label-free, high-throughput screening based ...
Conventional high throughput screening for clinical candidates cannot evaluate over 99% of commercially available molecules, thereby restricting the accessible chemical search space for therapeutic ...
SCIEX launched the Echo ® MS+ system at SLAS 2024. According to the company, the system couples proprietary acoustic ejection mass spectrometry technology and open port interface (OPI) sampling with ...
“ The Carterra Vega platform is a technological leap forward—a true step change. Faster hit discovery with 48 parallel ...
Scientists often turn to high throughput screening (HTS) to quickly assay large-scale compound libraries against a desired target, accelerating life science research. New technologies and relevant ...
Optimized chemistry enables direct synthesis of up to 500 bp double stranded fragments “Using our chemical synthesis platform we are able to directly synthesize Twist Multiplexed Gene Fragments as ...
The Echo® MS+ system unlocks enhanced high-throughput screening capability by bringing acoustic ejection mass spectrometry (AEMS) approaches to the SCIEX ZenoTOF 7600 system. FRAMINGHAM, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results